BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 3865355)

  • 1. Treatment of anaerobic infections: an overview.
    Finegold SM
    Scand J Infect Dis Suppl; 1985; 46():89-95. PubMed ID: 3865355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial therapy for anaerobic infections.
    Finegold SM
    Scand J Gastroenterol Suppl; 1984; 91():61-72. PubMed ID: 6588490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial therapy of anaerobic infections, 1991.
    Sanders CV; Aldridge KE
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):72S-79S. PubMed ID: 2041835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaerobic bacteria isolated from foot infections in diabetic patients: in vitro susceptibility to nine antibiotics.
    Ginunas VJ; Canawati HN; Sapico FL
    Clin Ther; 1984; 6(4):457-60. PubMed ID: 6467279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of newer antimicrobial agents in the treatment of mixed aerobic and anaerobic infections.
    Karam GH; Sanders CV; Aldridge KE
    Surg Gynecol Obstet; 1991; 172 Suppl():57-64. PubMed ID: 2024228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections.
    Aldridge KE
    Am J Surg; 1995 May; 169(5A Suppl):2S-7S. PubMed ID: 7755163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance and resistance transfer in anaerobic. A review.
    Tally FP; Malamy MH
    Scand J Gastroenterol Suppl; 1984; 91():21-30. PubMed ID: 6377471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects on antibacterial treatment of anaerobic infections.
    Nordbring F; Nord CE
    Scand J Infect Dis Suppl; 1982; 35():59-62. PubMed ID: 6762654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metronidazole is still the drug of choice for treatment of anaerobic infections.
    Löfmark S; Edlund C; Nord CE
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S16-23. PubMed ID: 20067388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
    Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
    J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic management of anaerobic infections.
    Brook I
    Hosp Pract (Off Ed); 1982 Aug; 17(8):203, 206-7, 210-11 passim. PubMed ID: 6807815
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
    Aldridge KE
    Eur J Surg Suppl; 1994; (573):31-7. PubMed ID: 7524793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of anaerobic septicemia.
    Kalager T; Solberg CO
    Scand J Infect Dis Suppl; 1985; 46():96-100. PubMed ID: 3865356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.
    Goldstein EJ; Citron DM; Vaidya SA; Warren YA; Tyrrell KL; Vreni Merriam C; Fernandez H
    Anaerobe; 2006 Apr; 12(2):63-6. PubMed ID: 16701615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.
    Tally FP; Cuchural GJ; Malamy MH
    Rev Infect Dis; 1984; 6 Suppl 1():S260-9. PubMed ID: 6326243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
    Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.